Exon skipping in ex vivo human skin highlights the potential of antisense oligonucleotide-mediated exon skipping as systemic treatment for recessive dystrophic epidermolysis bullosa

Activity: Talk and presentation › Professional or public presentation › Professional

Description

Abstract selected oral presentation:

Joint Dutch/ UK Clinical Genetics Societies Meeting 2024, 5 March 2024



Exon skipping in ex vivo human skin highlights the potential of antisense oligonucleotide-mediated exon skipping as systemic treatment for recessive dystrophic epidermolysis bullosa



A. Sandilands, F.C. Vermeer, J. Bremer, M. Conneely, B.A. Kader, W.H.I. McLean, R.P. Hickerson, P.C. van den Akker
Period5-Mar-2024
Event titleJoint Dutch/UK Clinical Genetics Societies Meeting 2024
Event typeConference
Degree of RecognitionInternational